Health Care Sector
895 health care stocks ranked by market capitalization, page 6 of 18. Updated October 12, 2026.
Today
+1.52%Health Care stocks ranked 251–300
| # | Symbol | Company | Price | % Change | Volume | Market Cap |
|---|---|---|---|---|---|---|
| 251 | SRPT | Sarepta Therapeutics Inc. | 17.85 | -1.98% | 3.02M | $1.89B |
| 252 | TRVI | Trevi Therapeutics Inc. | 13.19 | +2.85% | 5.03M | $1.88B |
| 253 | MESO | Mesoblast Limited ADR | 14.29 | +3.93% | 178.17K | $1.86B |
| 254 | ZYME | Zymeworks Inc. | 25.79 | +2.10% | 491.13K | $1.85B |
| 255 | LMAT | LeMaitre Vascular Inc. | 80.69 | +1.32% | 126.71K | $1.85B |
| 256 | GENB | Generate Biomedicines Inc. | 14.34 | +2.50% | 903.37K | $1.84B |
| 257 | ESTA | Establishment Labs Holdings Inc. | 61.67 | +1.75% | 299.66K | $1.84B |
| 258 | NTLA | Intellia Therapeutics Inc. | 13.07 | +3.73% | 8.15M | $1.83B |
| 259 | XNCR | Xencor Inc. | 24.63 | +0.53% | 1.15M | $1.83B |
| 260 | BHVN | Biohaven Ltd. | 12.08 | +1.26% | 1.37M | $1.82B |
| 261 | GPCR | Structure Therapeutics Inc. ADR | 25.54 | -0.51% | 593.23K | $1.82B |
| 262 | SGRY | Surgery Partners Inc. | 13.89 | +1.83% | 929.01K | $1.82B |
| 263 | BRVE | Braveheart Bio Inc. | 20.02 | +4.87% | 255.24K | $1.80B |
| 264 | URGN | UroGen Pharma Ltd. | 36.83 | -0.41% | 3.90M | $1.80B |
| 265 | SEPN | Septerna Inc. | 38.37 | +3.98% | 349.48K | $1.79B |
| 266 | ZBIO | Zenas BioPharma Inc. | 27.26 | +3.89% | 429.82K | $1.78B |
| 267 | XRAY | DENTSPLY SIRONA Inc. | 8.83 | +1.61% | 4.22M | $1.76B |
| 268 | NUVB | Nuvation Bio Inc. Class A | 5.00 | +1.01% | 2.96M | $1.76B |
| 269 | ABSI | Absci Corporation | 10.16 | +13.65% | 4.25M | $1.74B |
| 270 | PSNL | Personalis Inc. | 16.00 | -0.37% | 1.84M | $1.71B |
| 271 | NVCR | NovoCure Limited | 14.58 | +2.53% | 1.02M | $1.70B |
| 272 | ANIP | ANI Pharmaceuticals Inc. | 73.89 | +2.65% | 540.84K | $1.70B |
| 273 | FRNM | Freenome Inc. | 15.78 | -0.19% | 558.76K | $1.70B |
| 274 | SNDA | Sonida Senior Living Inc. | 35.24 | -2.00% | 579.05K | $1.69B |
| 275 | CMPS | COMPASS Pathways Plc American Depository Shares | 12.00 | +4.62% | 2.28M | $1.66B |
| 276 | OCUL | Ocular Therapeutix Inc. | 7.54 | +0.40% | 2.63M | $1.66B |
| 277 | ATEC | Alphatec Holdings Inc. | 10.67 | +3.09% | 1.57M | $1.65B |
| 278 | KMTS | Kestra Medical Technologies Ltd. | 26.98 | +4.70% | 246.78K | $1.61B |
| 279 | STOK | Stoke Therapeutics Inc. | 24.74 | +3.30% | 918.96K | $1.60B |
| 280 | ARDT | Ardent Health Inc. | 11.30 | +2.08% | 560.12K | $1.59B |
| 281 | ETON | Eton Pharmaceuticals Inc. | 55.21 | +0.84% | 371.14K | $1.58B |
| 282 | QURE | uniQure N.V. | 22.59 | +0.22% | 2.05M | $1.57B |
| 283 | ALHC | Alignment Healthcare Inc. | 7.55 | -13.38% | 26.06M | $1.57B |
| 284 | PAHC | Phibro Animal Health Corporation Class A | 38.30 | +2.41% | 235.92K | $1.56B |
| 285 | KRSA | Korsana Biosciences Inc. | 33.92 | +1.22% | 45.92K | $1.54B |
| 286 | INVA | Innoviva Inc. | 21.21 | +1.63% | 507.58K | $1.53B |
| 287 | RARE | Ultragenyx Pharmaceutical Inc. | 15.48 | +1.24% | 2.93M | $1.53B |
| 288 | SNDX | Syndax Pharmaceuticals Inc. | 16.99 | +0.53% | 1.46M | $1.52B |
| 289 | IMCR | Immunocore Holdings plc ADR | 29.39 | +1.03% | 452.84K | $1.51B |
| 290 | MAZE | Maze Therapeutics Inc. | 27.11 | +4.75% | 670.92K | $1.51B |
| 291 | KLRA | Kailera Therapeutics Inc. | 11.61 | +16.10% | 2.18M | $1.51B |
| 292 | COAG | Hemab Therapeutics Holdings Inc. | 31.62 | +2.36% | 619.09K | $1.48B |
| 293 | RAPP | Rapport Therapeutics Inc. | 30.65 | +2.68% | 247.91K | $1.47B |
| 294 | TSHA | Taysha Gene Therapies Inc. | 4.49 | +1.35% | 5.38M | $1.46B |
| 295 | PCRX | Pacira BioSciences Inc. | 36.31 | -0.22% | 4.69M | $1.45B |
| 296 | GHRS | GH Research PLC | 21.11 | +3.23% | 146.04K | $1.45B |
| 297 | OMER | Omeros Corporation | 19.83 | +3.71% | 793.93K | $1.44B |
| 298 | HCSG | Healthcare Services Group Inc. | 20.59 | -0.34% | 446.30K | $1.41B |
| 299 | NKTR | Nektar Therapeutics | 41.17 | +0.91% | 1.17M | $1.41B |
| 300 | INBX | Inhibrx Biosciences Inc. | 95.01 | +2.43% | 86.82K | $1.40B |
Prices as of Oct 12, 12:10 AM EDT. Market data is delayed at least 15 minutes and provided for informational purposes only. Not investment advice. Full disclaimer